CD4 and neoplasm: In addition to high SCARF1 expression correlating with a good outcome, our functional assays also suggest that SCARF1 may have an active anti-tumoral role for by promoting the recruitment of effector CD4+ T cells rather than tumor promoting regulatory T cells (Tregs).